<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03456622</url>
  </required_header>
  <id_info>
    <org_study_id>ORTHO.CR.GH59</org_study_id>
    <nct_id>NCT03456622</nct_id>
  </id_info>
  <brief_title>BC Study of G7 Cup and Compatible Femoral Stems</brief_title>
  <official_title>A Prospective, Observational, Multi-centre, Cohort Study of the G7™Acetabular System Used With Compatible Femoral Stems in Patients With Degenerative Disease of the Hip</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective , observational, multi-centre, cohort study of the G7™ Acetabular System used&#xD;
      with compatible femoral stems in patients with degenerative disease of the hip.&#xD;
&#xD;
      The study will be enrolled onto Beyond Compliance.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The UK Beyond Compliance is a joint effort between implant manufacturers, implanting surgeons&#xD;
      adopting our products, and the Beyond Compliance Advisory Group, all of whom are looking to&#xD;
      ensure the safe and stepwise introduction of new or modified implants to the market in the&#xD;
      interest of patients.&#xD;
&#xD;
      The G7 Acetabular Cup System is Biomet multi-bearing acetabular platform with a wide range of&#xD;
      acetabular shell options recently launched. There is a need to provide evidence on the safety&#xD;
      and performance of this cup to support the product in different markets.&#xD;
&#xD;
      The purpose of this multicenter study is to assess the clinical performance of the G7&#xD;
      acetabular system under standard condition of use. The data will help Biomet to gain 3A ODEP&#xD;
      rating in 4 years and up to 10 year rating&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 2015</start_date>
  <completion_date type="Anticipated">December 2028</completion_date>
  <primary_completion_date type="Anticipated">June 2028</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Rate of failure.</measure>
    <time_frame>3 years</time_frame>
    <description>The survival function of the device will be estimated using Kaplan-Meier methods</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of failure.</measure>
    <time_frame>5 years</time_frame>
    <description>The survival function of the device will be estimated using Kaplan-Meier methods</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of failure.</measure>
    <time_frame>10 years</time_frame>
    <description>The survival function of the device will be estimated using Kaplan-Meier methods</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oxford Hip Score</measure>
    <time_frame>Change from pre-op score at 1 year post-op</time_frame>
    <description>Assessing function outcome - Oxford Hip Score, score range 0 (worst) to 48 (best)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxford Hip Score</measure>
    <time_frame>3 years after primary device implantation</time_frame>
    <description>Assessing function outcome - Oxford Hip Score, score range 0 (worst) to 48</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Score questionnaire</measure>
    <time_frame>Change from pre-op score at 1 year post-op</time_frame>
    <description>Assessing function outcome - Harris Hip Score - score range 90 - 100 (excellent), 80 - 90 (good), 70 - 79 (fair), 60 - 69 (poor) and under 60 (very poor)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Score questionnaire</measure>
    <time_frame>Change from pre-op score at 3 year post-op</time_frame>
    <description>Assessing function outcome - Harris Hip Score - score range 90 - 100 (excellent), 80 - 90 (good), 70 - 79 (fair), 60 - 69 (poor) and under 60 (very poor)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EuroQol Five Dimensions Questionnaire (EQ-5D-3L)</measure>
    <time_frame>Change from pre-op score at 1 year post-op</time_frame>
    <description>Reporting on quality of life - scores range from -0.11 (i.e., 33333) to 1.0 (i.e., 11111) on scale where 0.0 =death and 1.0 =perfect health.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EuroQol Five Dimensions Questionnaire (EQ-5D-3L)</measure>
    <time_frame>Change from pre-op score at 3 year post-op</time_frame>
    <description>Reporting on quality of life - scores range from -0.11 (i.e., 33333) to 1.0 (i.e., 11111) on scale where 0.0 =death and 1.0 =perfect health.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hip disability and Osteoarthiritis Outcome Score (HOOS)</measure>
    <time_frame>Change from pre-op score at 1 year post-op</time_frame>
    <description>Patient Reported Outcome - score range 0 (worst ) to 100 (best)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hip disability and Osteoarthiritis Outcome Score (HOOS)</measure>
    <time_frame>Change from pre-op score at 3 year post-op</time_frame>
    <description>Patient Reported Outcome - score range 0 (worst ) to 100 (best)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic assessment</measure>
    <time_frame>1 year post-op</time_frame>
    <description>Assessing radiolucency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic assessment</measure>
    <time_frame>3 year post-op</time_frame>
    <description>Assessing radiolucency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Event Reporting</measure>
    <time_frame>recorded at pre-op, prior to discharge, 2-8 weeks, 6 months, 1 year, 3 years, 5 years &amp; 10 years.</time_frame>
    <description>Patient reported event.</description>
  </secondary_outcome>
  <enrollment type="Actual">230</enrollment>
  <condition>Non-inflammatory Degenerative Joint Disease</condition>
  <condition>Osteoarthritis</condition>
  <condition>Avascular Necrosis</condition>
  <condition>Rheumatoid Arthritis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All individuals who receive the study device, meet inclusion/exclusion criteria and&#xD;
        provided nformed consent.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male and female ≥18 years&#xD;
&#xD;
          -  Non-inflammatory degenerative joint disease including osteoarthritis and avascular&#xD;
             necrosis, suitable for unilateral primary hip replacement;&#xD;
&#xD;
          -  Rheumatoid arthritis;&#xD;
&#xD;
          -  Correction of functional deformity;&#xD;
&#xD;
          -  Voluntary written Informed Consent obtained&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
        Pre-operative:&#xD;
&#xD;
          -  Prospect for recovery to independent mobility compromised by known coexistent medical&#xD;
             problems;&#xD;
&#xD;
          -  Requiring revision hip replacement;&#xD;
&#xD;
          -  Requiring bilateral hip replacement;&#xD;
&#xD;
          -  Previous hip replacement (resurfacing or THR) on the contralateral side and whose&#xD;
             outcome is achieving an Oxford Hip score &lt;18 points;&#xD;
&#xD;
          -  Likely post-operative leg length inequality &gt;5cm;&#xD;
&#xD;
          -  Neuromuscular disease affecting hip (Parkinson's, cerebral palsy, other spasticity);&#xD;
&#xD;
          -  Primary or metastatic tumour involving this hip;&#xD;
&#xD;
          -  Loss of abductor musculature, poor bone stock, or poor skin coverage around the hip&#xD;
             joint;&#xD;
&#xD;
          -  Previous organ transplant;&#xD;
&#xD;
          -  Previous arthrodesis or excision arthroplasty&#xD;
&#xD;
          -  Abnormal acetabulum:&#xD;
&#xD;
               -  Acetabular deficiency - &gt;2cm superior loss acetabular dome or &gt;1.5cm protrusion&#xD;
                  acetabulae or wall deficiency&gt; half a wall;&#xD;
&#xD;
               -  Dysplasia (DDH) with &gt;2.5cm subluxation or complete dislocation;&#xD;
&#xD;
          -  Body mass index &gt; 40kg/m2;&#xD;
&#xD;
          -  Active or previous or suspected infection in this hip;&#xD;
&#xD;
          -  Sepsis or osteomyelitis;&#xD;
&#xD;
          -  Known sensitivity to device materials;&#xD;
&#xD;
          -  Women judged by the investigator to be of childbearing potential who are pregnant,&#xD;
             nursing, or planning to become pregnant, and those who do not agree to remain on an&#xD;
             acceptable method of birth control throughout the entire study period;&#xD;
&#xD;
          -  Unable to provide informed consent (insufficient English, cognitive disorder such as&#xD;
             dementia, psychiatric illness);&#xD;
&#xD;
          -  Unable to complete follow-ups (life expectancy &lt;5 years, insufficient English, lives&#xD;
             overseas, unable to return easily).&#xD;
&#xD;
        Intra-operative:&#xD;
&#xD;
          -  Abnormal abductor mechanism - trochanter escape &gt; 1.5cm or gluteus medius totally&#xD;
             non-functional or trochanter absence;&#xD;
&#xD;
          -  Unavailability of required size of prosthesis;&#xD;
&#xD;
          -  Abnormal acetabulum:&#xD;
&#xD;
               -  Acetabular deficiency - &gt;2cm superior loss acetabular dome or &gt;1.5cm protrusion&#xD;
                  acetabulae or wall deficiency&gt; half a wall;&#xD;
&#xD;
               -  Dysplasia (DDH) with &gt;2.5cm subluxation or complete dislocation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The Royal Bournemouth Hospital</name>
      <address>
        <city>Bournemouth</city>
        <zip>BH7 7DW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>January 12, 2018</study_first_submitted>
  <study_first_submitted_qc>March 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2018</study_first_posted>
  <last_update_submitted>December 21, 2020</last_update_submitted>
  <last_update_submitted_qc>December 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>G7</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Necrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

